Company Filing History:
Years Active: 2015-2018
Title: Pierre-Olivier Goineau: Innovating in Cancer Treatment
Introduction
Pierre-Olivier Goineau is a notable inventor based in Lyons, France. He has made significant contributions to the field of medicine, particularly in cancer treatment, through his innovative inventions and patents. With a total of two patents to his name, Goineau is dedicated to developing solutions that can potentially improve the lives of patients suffering from serious health conditions.
Latest Patents
Pierre-Olivier Goineau's latest patents focus on erythrocytes containing arginine deiminase. These innovations pertain to the preparation of medicinal products aimed at lowering the plasma concentration of arginine in vivo. This approach is particularly significant in the treatment of arginine-dependent tumors, such as hepatocarcinoma and malignant melanoma. Furthermore, the patents address the inhibition of nitric oxide synthesis and propose strategies for the prevention and/or treatment of septic shock, highlighting the therapeutic potential of his work.
Career Highlights
Goineau is affiliated with Erytech Pharma, a company that stands at the forefront of developing innovative treatments for serious medical conditions. His work is instrumental in advancing therapeutic strategies that target specific biological pathways, demonstrating his commitment to oncology and patient care.
Collaborations
In his endeavors, Pierre-Olivier Goineau collaborates closely with his coworker, Yann Godfrin. Together, they contribute to the research and development of cutting-edge solutions that aim to address critical health challenges. This collaborative approach enhances the innovation process and fosters a productive environment for advancing their projects.
Conclusion
Overall, Pierre-Olivier Goineau exemplifies the spirit of innovation in the medical field. Through his patents and contributions at Erytech Pharma, he continues to work towards breakthroughs that may offer hope to patients battling cancer and other serious ailments. His efforts reflect the importance of research and innovation in enhancing healthcare outcomes.